Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q3 2023 vs. Q2 2023
How the institutions holding Lakefront Biotherapeutics NV changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 73 | −2 |
| Shares | 19.7M | 167.3K | 19.2M | −370.0K (−1.9%) |
| Value | $801.4M | $6.80M | $662.4M | −$132.2M (−16.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighVista Strategies LLC | 13,647 | $471.5K | 0.22% |
| Bank of Montreal | 7,316 | $265.6K | 0.00% |
| Voloridge Investment Management, LLC | 7,456 | $257.6K | 0.00% |
| Dimensional Fund Advisors LP | 7,107 | $245.5K | 0.00% |
| Barclays PLC | 6,200 | $214.2K | 0.00% |
| Clear Street Markets LLC | 186 | $6.00K | 0.00% |
Sold out (8)
Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deutsche Bank AG | 294,207 | $12.0M |
| Logos Global Management LP | 250,000 | $10.2M |
| Marshall Wace, LLP | 43,615 | $1.77M |
| Trexquant Investment LP | 12,434 | $505.6K |
| Engineers Gate Manager LP | 5,574 | $226.6K |
| Simplex Trading, LLC | 1,355 | $55.0K |
| Parallel Advisors, LLC | 9 | $366 |
| Ronald Blue Trust, Inc. | 4 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 167,274 | $6.80M |